Aregahegn Yifru
Novartis (United States)(US)
Publications by Year
Research Areas
Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Tuberculosis Research and Epidemiology
Most-Cited Works
- → Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection(2012)116 cited
- → Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae – Identification of LYS228(2018)58 cited
- → Potent Nonimmunosuppressive Cyclophilin Inhibitors With Improved Pharmaceutical Properties and Decreased Transporter Inhibition(2014)31 cited
- → Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, Oxazolidinone and Isoxazoline(2018)27 cited
- → Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria(2021)27 cited
- → Development of a cyclosporin A derivative with excellent anti-hepatitis C virus potency(2017)4 cited
- → CCDC 2059541: Experimental Crystal Structure Determination(2021)
- → CCDC 2059546: Experimental Crystal Structure Determination(2021)
- → CCDC 2059545: Experimental Crystal Structure Determination(2021)
- → CCDC 2059543: Experimental Crystal Structure Determination(2021)